Industry Research Reports

Home > Reports > Service & Software > Global Nuclear Medicine Software Market Research Report 2026

Global Nuclear Medicine Software Market Research Report 2026

Industry: Service & Software

Published Date: 2026-01-14

Pages: 119 Pages

Report ld: 5649839

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nuclear Medicine Software Market Size(US$)

CAGR 2026-2032

5.6%

Market Size,2032

USD 173

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 124 million

Market Forecast in 2032(Value)

US$ 173 million

CAGR

5.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Nuclear Medicine Software market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

Nuclear Medicine Software is a computer program system specifically designed for the entire workflow of nuclear medicine imaging, encompassing every stage from patient management and image acquisition to reconstruction, processing, analysis, and report generation. Its core task is to process the signals of radioactive tracer distribution within the body, captured by devices such as gamma cameras, SPECT, or PET scanners, and convert them into diagnostic anatomical-functional fusion images using specialized algorithms. This software not only provides quantitative analysis tools but also deeply integrates artificial intelligence technology to enhance image quality and assist in lesion detection and segmentation. As an intelligent hub connecting imaging equipment, hospital information systems, and clinical decision-making, nuclear medicine software is a key technological platform for improving diagnostic accuracy, optimizing workflows, and supporting cutting-edge research.

The costs of Nuclear Medicine Software primarily include substantial research and development investments (algorithm development, clinical validation), ongoing regulatory certification fees, and customer customization and technical support costs. Its gross profit margin is typically very high, reaching 70%-85% for standard products. This is mainly because its core value lies in intellectual property and software licenses; once developed, the marginal cost of replication is extremely low. The revenue model is primarily based on software licensing fees, annual maintenance fees, and fees charged per analysis module.

The current Nuclear Medicine Software market is undergoing a period of rapid growth and transformation driven by technological advancements. With the increasing adoption of PET/CT and PET/MR technologies and the emergence of new radiopharmaceuticals, the market is experiencing a surge in demand for precise quantitative analysis and multimodal fusion, driving the evolution of software from basic imaging tools to intelligent diagnostic platforms. The deep integration of artificial intelligence is a core trend, significantly improving image reconstruction quality and the efficiency and accuracy of automatic lesion detection and quantitative analysis. The market is dominated by international giants, but cloud-based SaaS models and third-party AI software companies are introducing new dimensions of competition. Simultaneously, driven by the development of precision medicine and integrated diagnosis and treatment, software applications are expanding into areas such as radiotherapy planning, neuroscience, and new drug development. Regulatory compliance and data security requirements are also becoming increasingly stringent, resulting in a market characterized by high added value and high technological barriers.

This report delivers a comprehensive overview of the global Nuclear Medicine Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nuclear Medicine Software. The Nuclear Medicine Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Nuclear Medicine Software market comprehensively. Regional market sizes by Type, by Application, by Deployment, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Nuclear Medicine Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

iQ IMAGE
Mediso
Segami
Hermes Medical Solutions
MIM Software Inc
LabLogic
scintido
Gamma Gurus
Mirion Medical
PAIRE
GE HealthCare
Inter Medical
Sirona

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Drug Management
Radiation Management
Other

Segment by Application

Clinical Diagnosis
Research
Others

Segment by Category

On Premise Software
Cloud-Based Software

Segment by Division

Image Acquisition and Reconstruction Software
Image Processing and Analysis Software
Reporting and Information Management Software
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Deployment, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Nuclear Medicine Software companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nuclear Medicine Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Drug Management

1.2.3 Radiation Management

1.2.4 Other

1.3 Market by Deployment

1.3.1 Global Nuclear Medicine Software Market Size Growth Rate by Deployment: 2021 vs 2025 vs 2032

1.3.2 On Premise Software

1.3.3 Cloud-Based Software

1.4 Market by Function

1.4.1 Global Nuclear Medicine Software Market Size Growth Rate by Function: 2021 vs 2025 vs 2032

1.4.2 Image Acquisition and Reconstruction Software

1.4.3 Image Processing and Analysis Software

1.4.4 Reporting and Information Management Software

1.4.5 Others

1.5 Market by Application

1.5.1 Global Nuclear Medicine Software Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Clinical Diagnosis

1.5.3 Research

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Nuclear Medicine Software Market Perspective (2021–2032)

2.2 Global Nuclear Medicine Software Growth Trends by Region

2.2.1 Global Nuclear Medicine Software Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Nuclear Medicine Software Historic Market Size by Region (2021–2026)

2.2.3 Nuclear Medicine Software Forecasted Market Size by Region (2027–2032)

2.3 Nuclear Medicine Software Market Dynamics

2.3.1 Nuclear Medicine Software Industry Trends

2.3.2 Nuclear Medicine Software Market Drivers

2.3.3 Nuclear Medicine Software Market Challenges

2.3.4 Nuclear Medicine Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nuclear Medicine Software Players by Revenue

3.1.1 Global Top Nuclear Medicine Software Players by Revenue (2021–2026)

3.1.2 Global Nuclear Medicine Software Revenue Market Share by Players (2021–2026)

3.2 Global Top Nuclear Medicine Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Nuclear Medicine Software Revenue

3.4 Global Nuclear Medicine Software Market Concentration Ratio

3.4.1 Global Nuclear Medicine Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Software Revenue in 2025

3.5 Global Key Players of Nuclear Medicine Software Head Offices and Areas Served

3.6 Global Key Players of Nuclear Medicine Software, Products and Applications

3.7 Global Key Players of Nuclear Medicine Software, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Nuclear Medicine Software Breakdown Data by Type

4.1 Global Nuclear Medicine Software Historic Market Size by Type (2021–2026)

4.2 Global Nuclear Medicine Software Forecasted Market Size by Type (2027–2032)

5 Nuclear Medicine Software Breakdown Data by Application

5.1 Global Nuclear Medicine Software Historic Market Size by Application (2021–2026)

5.2 Global Nuclear Medicine Software Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Nuclear Medicine Software Market Size (2021–2032)

6.2 North America Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Nuclear Medicine Software Market Size by Country (2021–2026)

6.4 North America Nuclear Medicine Software Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nuclear Medicine Software Market Size (2021–2032)

7.2 Europe Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Nuclear Medicine Software Market Size by Country (2021–2026)

7.4 Europe Nuclear Medicine Software Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Nuclear Medicine Software Market Size (2021–2032)

8.2 Asia-Pacific Nuclear Medicine Software Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Nuclear Medicine Software Market Size by Region (2021–2026)

8.4 Asia-Pacific Nuclear Medicine Software Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Nuclear Medicine Software Market Size (2021–2032)

9.2 Latin America Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Nuclear Medicine Software Market Size by Country (2021–2026)

9.4 Latin America Nuclear Medicine Software Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nuclear Medicine Software Market Size (2021–2032)

10.2 Middle East & Africa Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Nuclear Medicine Software Market Size by Country (2021–2026)

10.4 Middle East & Africa Nuclear Medicine Software Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 iQ IMAGE

11.1.1 iQ IMAGE Company Details

11.1.2 iQ IMAGE Business Overview

11.1.3 iQ IMAGE Nuclear Medicine Software Introduction

11.1.4 iQ IMAGE Revenue in Nuclear Medicine Software Business (2021–2026)

11.1.5 iQ IMAGE Recent Development

11.2 Mediso

11.2.1 Mediso Company Details

11.2.2 Mediso Business Overview

11.2.3 Mediso Nuclear Medicine Software Introduction

11.2.4 Mediso Revenue in Nuclear Medicine Software Business (2021–2026)

11.2.5 Mediso Recent Development

11.3 Segami

11.3.1 Segami Company Details

11.3.2 Segami Business Overview

11.3.3 Segami Nuclear Medicine Software Introduction

11.3.4 Segami Revenue in Nuclear Medicine Software Business (2021–2026)

11.3.5 Segami Recent Development

11.4 Hermes Medical Solutions

11.4.1 Hermes Medical Solutions Company Details

11.4.2 Hermes Medical Solutions Business Overview

11.4.3 Hermes Medical Solutions Nuclear Medicine Software Introduction

11.4.4 Hermes Medical Solutions Revenue in Nuclear Medicine Software Business (2021–2026)

11.4.5 Hermes Medical Solutions Recent Development

11.5 MIM Software Inc

11.5.1 MIM Software Inc Company Details

11.5.2 MIM Software Inc Business Overview

11.5.3 MIM Software Inc Nuclear Medicine Software Introduction

11.5.4 MIM Software Inc Revenue in Nuclear Medicine Software Business (2021–2026)

11.5.5 MIM Software Inc Recent Development

11.6 LabLogic

11.6.1 LabLogic Company Details

11.6.2 LabLogic Business Overview

11.6.3 LabLogic Nuclear Medicine Software Introduction

11.6.4 LabLogic Revenue in Nuclear Medicine Software Business (2021–2026)

11.6.5 LabLogic Recent Development

11.7 scintido

11.7.1 scintido Company Details

11.7.2 scintido Business Overview

11.7.3 scintido Nuclear Medicine Software Introduction

11.7.4 scintido Revenue in Nuclear Medicine Software Business (2021–2026)

11.7.5 scintido Recent Development

11.8 Gamma Gurus

11.8.1 Gamma Gurus Company Details

11.8.2 Gamma Gurus Business Overview

11.8.3 Gamma Gurus Nuclear Medicine Software Introduction

11.8.4 Gamma Gurus Revenue in Nuclear Medicine Software Business (2021–2026)

11.8.5 Gamma Gurus Recent Development

11.9 Mirion Medical

11.9.1 Mirion Medical Company Details

11.9.2 Mirion Medical Business Overview

11.9.3 Mirion Medical Nuclear Medicine Software Introduction

11.9.4 Mirion Medical Revenue in Nuclear Medicine Software Business (2021–2026)

11.9.5 Mirion Medical Recent Development

11.10 PAIRE

11.10.1 PAIRE Company Details

11.10.2 PAIRE Business Overview

11.10.3 PAIRE Nuclear Medicine Software Introduction

11.10.4 PAIRE Revenue in Nuclear Medicine Software Business (2021–2026)

11.10.5 PAIRE Recent Development

11.11 GE HealthCare

11.11.1 GE HealthCare Company Details

11.11.2 GE HealthCare Business Overview

11.11.3 GE HealthCare Nuclear Medicine Software Introduction

11.11.4 GE HealthCare Revenue in Nuclear Medicine Software Business (2021–2026)

11.11.5 GE HealthCare Recent Development

11.12 Inter Medical

11.12.1 Inter Medical Company Details

11.12.2 Inter Medical Business Overview

11.12.3 Inter Medical Nuclear Medicine Software Introduction

11.12.4 Inter Medical Revenue in Nuclear Medicine Software Business (2021–2026)

11.12.5 Inter Medical Recent Development

11.13 Sirona

11.13.1 Sirona Company Details

11.13.2 Sirona Business Overview

11.13.3 Sirona Nuclear Medicine Software Introduction

11.13.4 Sirona Revenue in Nuclear Medicine Software Business (2021–2026)

11.13.5 Sirona Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Nuclear Medicine Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Drug Management

Table 3. Key Players of Radiation Management

Table 4. Key Players of Other

Table 5. Global Nuclear Medicine Software Market Size Growth Rate by Deployment (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of On Premise Software

Table 7. Key Players of Cloud-Based Software

Table 8. Global Nuclear Medicine Software Market Size Growth Rate by Function (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Image Acquisition and Reconstruction Software

Table 10. Key Players of Image Processing and Analysis Software

Table 11. Key Players of Reporting and Information Management Software

Table 12. Key Players of Others

Table 13. Global Nuclear Medicine Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Nuclear Medicine Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global Nuclear Medicine Software Market Size by Region (US$ Million), 2021–2026

Table 16. Global Nuclear Medicine Software Market Share by Region (2021–2026)

Table 17. Global Nuclear Medicine Software Forecasted Market Size by Region (US$ Million), 2027–2032

Table 18. Global Nuclear Medicine Software Market Share by Region (2027–2032)

Table 19. Nuclear Medicine Software Market Trends

Table 20. Nuclear Medicine Software Market Drivers

Table 21. Nuclear Medicine Software Market Challenges

Table 22. Nuclear Medicine Software Market Restraints

Table 23. Global Nuclear Medicine Software Revenue by Players (US$ Million), 2021–2026

Table 24. Global Nuclear Medicine Software Market Share by Players (2021–2026)

Table 25. Global Top Nuclear Medicine Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nuclear Medicine Software Revenue, 2025

Table 26. Ranking of Global Top Nuclear Medicine Software Companies by Revenue (US$ Million) in 2025

Table 27. Global 5 Largest Players Market Share by Nuclear Medicine Software Revenue (CR5 and HHI), 2021–2026

Table 28. Global Key Players of Nuclear Medicine Software, Headquarters and Area Served

Table 29. Global Key Players of Nuclear Medicine Software, Products and Applications

Table 30. Global Key Players of Nuclear Medicine Software, Date of General Availability (GA)

Table 31. Mergers and Acquisitions, Expansion Plans

Table 32. Global Nuclear Medicine Software Market Size by Type (US$ Million), 2021–2026

Table 33. Global Nuclear Medicine Software Revenue Market Share by Type (2021–2026)

Table 34. Global Nuclear Medicine Software Forecasted Market Size by Type (US$ Million), 2027–2032

Table 35. Global Nuclear Medicine Software Revenue Market Share by Type (2027–2032)

Table 36. Global Nuclear Medicine Software Market Size by Application (US$ Million), 2021–2026

Table 37. Global Nuclear Medicine Software Revenue Market Share by Application (2021–2026)

Table 38. Global Nuclear Medicine Software Forecasted Market Size by Application (US$ Million), 2027–2032

Table 39. Global Nuclear Medicine Software Revenue Market Share by Application (2027–2032)

Table 40. North America Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. North America Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026

Table 42. North America Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032

Table 43. Europe Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Europe Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026

Table 45. Europe Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032

Table 46. Asia-Pacific Nuclear Medicine Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 47. Asia-Pacific Nuclear Medicine Software Market Size by Region (US$ Million), 2021–2026

Table 48. Asia-Pacific Nuclear Medicine Software Market Size by Region (US$ Million), 2027–2032

Table 49. Latin America Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Latin America Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026

Table 51. Latin America Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032

Table 52. Middle East & Africa Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Middle East & Africa Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026

Table 54. Middle East & Africa Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032

Table 55. iQ IMAGE Company Details

Table 56. iQ IMAGE Business Overview

Table 57. iQ IMAGE Nuclear Medicine Software Product

Table 58. iQ IMAGE Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 59. iQ IMAGE Recent Development

Table 60. Mediso Company Details

Table 61. Mediso Business Overview

Table 62. Mediso Nuclear Medicine Software Product

Table 63. Mediso Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 64. Mediso Recent Development

Table 65. Segami Company Details

Table 66. Segami Business Overview

Table 67. Segami Nuclear Medicine Software Product

Table 68. Segami Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 69. Segami Recent Development

Table 70. Hermes Medical Solutions Company Details

Table 71. Hermes Medical Solutions Business Overview

Table 72. Hermes Medical Solutions Nuclear Medicine Software Product

Table 73. Hermes Medical Solutions Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 74. Hermes Medical Solutions Recent Development

Table 75. MIM Software Inc Company Details

Table 76. MIM Software Inc Business Overview

Table 77. MIM Software Inc Nuclear Medicine Software Product

Table 78. MIM Software Inc Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 79. MIM Software Inc Recent Development

Table 80. LabLogic Company Details

Table 81. LabLogic Business Overview

Table 82. LabLogic Nuclear Medicine Software Product

Table 83. LabLogic Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 84. LabLogic Recent Development

Table 85. scintido Company Details

Table 86. scintido Business Overview

Table 87. scintido Nuclear Medicine Software Product

Table 88. scintido Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 89. scintido Recent Development

Table 90. Gamma Gurus Company Details

Table 91. Gamma Gurus Business Overview

Table 92. Gamma Gurus Nuclear Medicine Software Product

Table 93. Gamma Gurus Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 94. Gamma Gurus Recent Development

Table 95. Mirion Medical Company Details

Table 96. Mirion Medical Business Overview

Table 97. Mirion Medical Nuclear Medicine Software Product

Table 98. Mirion Medical Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 99. Mirion Medical Recent Development

Table 100. PAIRE Company Details

Table 101. PAIRE Business Overview

Table 102. PAIRE Nuclear Medicine Software Product

Table 103. PAIRE Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 104. PAIRE Recent Development

Table 105. GE HealthCare Company Details

Table 106. GE HealthCare Business Overview

Table 107. GE HealthCare Nuclear Medicine Software Product

Table 108. GE HealthCare Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 109. GE HealthCare Recent Development

Table 110. Inter Medical Company Details

Table 111. Inter Medical Business Overview

Table 112. Inter Medical Nuclear Medicine Software Product

Table 113. Inter Medical Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 114. Inter Medical Recent Development

Table 115. Sirona Company Details

Table 116. Sirona Business Overview

Table 117. Sirona Nuclear Medicine Software Product

Table 118. Sirona Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026

Table 119. Sirona Recent Development

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Authors List of This Report

List of Figures

Figure 1. Nuclear Medicine Software Picture

Figure 2. Global Nuclear Medicine Software Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Nuclear Medicine Software Market Share by Type: 2025 vs 2032

Figure 4. Drug Management Features

Figure 5. Radiation Management Features

Figure 6. Other Features

Figure 7. Global Nuclear Medicine Software Market Size Comparison by Deployment (US$ Million), 2021–2032

Figure 8. On Premise Software Features

Figure 9. Cloud-Based Software Features

Figure 10. Global Nuclear Medicine Software Market Size Comparison by Function (US$ Million), 2021–2032

Figure 11. Image Acquisition and Reconstruction Software Features

Figure 12. Image Processing and Analysis Software Features

Figure 13. Reporting and Information Management Software Features

Figure 14. Others Features

Figure 15. Global Nuclear Medicine Software Market Size by Application (US$ Million), 2021–2032

Figure 16. Global Nuclear Medicine Software Market Share by Application: 2025 vs 2032

Figure 17. Clinical Diagnosis Case Studies

Figure 18. Research Case Studies

Figure 19. Others Case Studies

Figure 20. Nuclear Medicine Software Report Years Considered

Figure 21. Global Nuclear Medicine Software Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Nuclear Medicine Software Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Nuclear Medicine Software Market Share by Region: 2025 vs 2032

Figure 24. Global Nuclear Medicine Software Market Share by Players in 2025

Figure 25. Global Nuclear Medicine Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Nuclear Medicine Software Revenue in 2025

Figure 27. North America Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Nuclear Medicine Software Market Share by Country (2021–2032)

Figure 29. United States Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Nuclear Medicine Software Market Share by Country (2021–2032)

Figure 33. Germany Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Nuclear Medicine Software Market Share by Region (2021–2032)

Figure 41. China Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Nuclear Medicine Software Market Share by Country (2021–2032)

Figure 49. Mexico Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Nuclear Medicine Software Market Share by Country (2021–2032)

Figure 53. Israel Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. iQ IMAGE Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 57. Mediso Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 58. Segami Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 59. Hermes Medical Solutions Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 60. MIM Software Inc Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 61. LabLogic Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 62. scintido Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 63. Gamma Gurus Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 64. Mirion Medical Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 65. PAIRE Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 66. GE HealthCare Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 67. Inter Medical Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 68. Sirona Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Nuclear Medicine Software market? zhanKai

The top companies in the global Nuclear Medicine Software market are iQ IMAGE、Mediso、Segami.

What was the global market size of Nuclear Medicine Software in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Nuclear Medicine Software market size from 2026 to 2032? shouQi

What was the global market size of Nuclear Medicine Software in 2032? shouQi

Related Reports

Nuclear Medicine Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Medicine Software was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 173 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 103
USD 3950.00
(Single User License)
Global Nuclear Medicine Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nuclear Medicine Software market is projected to grow from US$ 118 million in 2025 to US$ 173 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-14
Pages: 136
USD 4900.00
(Single User License)
Global Nuclear Medicine Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nuclear Medicine Software market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 173 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published Date: 2026-01-14
Pages: 94
USD 4250.00
(Single User License)
Global Nuclear Medicine Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Medicine Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 102
USD 4900.00
(Single User License)
Global Nuclear Medicine Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Medicine Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 65
USD 4250.00
(Single User License)
Nuclear Medicine Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Medicine Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 76
USD 3950.00
(Single User License)
Global Nuclear Medicine Software Market Research Report 2025
The global market for Nuclear Medicine Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 65
USD 2900.00
(Single User License)
Global Nuclear Medicine Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Nuclear Medicine Software Market
Published Date: 2024-04-08
Pages: 77
USD 4900.00
(Single User License)
Nuclear Medicine Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Nuclear Medicine Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-23
Pages: 77
USD 3950.00
(Single User License)
Global Nuclear Medicine Software Market Research Report 2024
The global Nuclear Medicine Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-08
Pages: 68
USD 2900.00
(Single User License)

Nuclear Medicine Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Medicine Software was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 173 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-01-14
Pages: 103
USD 3950.00 (Single User License)
Global Nuclear Medicine Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nuclear Medicine Software market is projected to grow from US$ 118 million in 2025 to US$ 173 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-14
Pages: 136
USD 4900.00 (Single User License)
Global Nuclear Medicine Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nuclear Medicine Software market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 173 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-01-14
Pages: 94
USD 4250.00 (Single User License)
Global Nuclear Medicine Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Medicine Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 102
USD 4900.00 (Single User License)
Global Nuclear Medicine Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Medicine Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 65
USD 4250.00 (Single User License)
Nuclear Medicine Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Medicine Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 76
USD 3950.00 (Single User License)
Global Nuclear Medicine Software Market Research Report 2025
The global market for Nuclear Medicine Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 65
USD 2900.00 (Single User License)
Global Nuclear Medicine Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Nuclear Medicine Software Market
Published: 2024-04-08
Pages: 77
USD 4900.00 (Single User License)
Nuclear Medicine Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Nuclear Medicine Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-23
Pages: 77
USD 3950.00 (Single User License)
Global Nuclear Medicine Software Market Research Report 2024
The global Nuclear Medicine Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 68
USD 2900.00 (Single User License)